Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management

被引:523
作者
Simoni, Jane M.
Kurth, Ann E.
Pearson, Cynthia R.
Pantalone, David W.
Merrill, Joseph O.
Frick, Pamela A.
机构
[1] Univ Washington, Dept Psychol, Seattle, WA 98195 USA
[2] Univ Washington, Sch Nursing CFAR, Seattle, WA 98195 USA
[3] Univ Washington, Sch Publ Hlth & Community Med, Seattle, WA 98195 USA
[4] Univ Washington, Dept Med, Seattle, WA 98195 USA
[5] Univ Washington, Dept Pharm, Seattle, WA 98195 USA
关键词
HIV/AIDS; antiretroviral; medication adherence; self-report; viral load;
D O I
10.1007/s10461-006-9078-6
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
A review of 77 studies employing self-report measures of antiretroviral adherence published 1/1996 through 8/2004 revealed great variety in adherence assessment item content, format, and response options. Recall periods ranged from 2 to 365 days (mode = 7 days). The most common cutoff for optimal adherence was 100% (21/48 studies, or 44%). In 27 of 34 recall periods (79%), self-reported adherence was associated with adherence as assessed with other indirect measures. Data from 57 of 67 recall periods (84%) indicated self-reported adherence was significantly associated with HIV-1 RNA viral load; in 16 of 26 (62%), it was associated with CD4 count. Clearly, the field would benefit from item standardization and a priori definitions and operationalizations of adherence. We conclude that even brief self-report measures of antiretroviral adherence can be robust, and recommend items and strategies for HIV research and clinical management.
引用
收藏
页码:227 / 245
页数:19
相关论文
共 106 条
[71]  
Melbourne K M, 1999, AIDS Read, V9, P329
[72]  
Miller L G, 2000, AIDS Read, V10, P177
[73]  
Miller L G, 2000, HIV Clin Trials, V1, P36
[74]   Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment [J].
Moatti, JP ;
Carrieri, MP ;
Spire, B ;
Gastaut, JA ;
Cassuto, JP ;
Moreau, J .
AIDS, 2000, 14 (02) :151-155
[75]   CONCURRENT AND PREDICTIVE-VALIDITY OF A SELF-REPORTED MEASURE OF MEDICATION ADHERENCE [J].
MORISKY, DE ;
GREEN, LW ;
LEVINE, DM .
MEDICAL CARE, 1986, 24 (01) :67-74
[76]  
Murri R, 2001, HIV Clin Trials, V2, P323
[77]  
Nieuwkerk P, 2001, ANTIVIR THER, V6, P97
[78]   Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response - A meta-analysis [J].
Nieuwkerk, PT ;
Oort, FJ .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 38 (04) :445-448
[79]   Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study [J].
Nieuwkerk, PT ;
Sprangers, MAG ;
Burger, DM ;
Hoetelmans, RMW ;
Hugen, PWH ;
Danner, SA ;
van der Ende, ME ;
Schneider, MME ;
Schrey, G ;
Meenhorst, PL ;
Sprenger, HG ;
Kauffmann, RH ;
Jambroes, M ;
Chesney, MA ;
de Wolf, F ;
Lange, JMA .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (16) :1962-1968
[80]   Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting [J].
Oyugi, JH ;
Byakika-Tusiime, J ;
Charlebois, ED ;
Kityo, C ;
Mugerwa, R ;
Mugyenyi, P ;
Bangsberg, DR .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (05) :1100-1102